Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

JetBlue Airways Corporation (JBLU): Are Hedge Funds Right About This Stock?

Page 1 of 2

Is JetBlue Airways Corporation (NASDAQ:JBLU) a good investment?

In today’s marketplace, there are plenty of gauges shareholders can use to track Mr. Market. Some of the most innovative are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best money managers can beat the broader indices by a significant amount (see just how much).

Equally as key, positive insider trading activity is another way to look at the investments you’re interested in. Just as you’d expect, there are a number of stimuli for an insider to cut shares of his or her company, but just one, very simple reason why they would initiate a purchase. Plenty of academic studies have demonstrated the market-beating potential of this tactic if “monkeys” understand what to do (learn more here).

Now that that’s out of the way, we’re going to discuss the newest info about JetBlue Airways Corporation (NASDAQ:JBLU).

How have hedgies been trading JetBlue Airways Corporation (NASDAQ:JBLU)?

In preparation for the third quarter, a total of 21 of the hedge funds we track were bullish in this stock, a change of 24% from the first quarter. With hedge funds’ capital changing hands, there exists a select group of key hedge fund managers who were upping their holdings substantially.

JetBlue Airways Corporation (NASDAQ:JBLU)When using filings from the hedgies we track, Matt Sirovich and Jeremy Mindich’s Scopia Capital had the most valuable position in JetBlue Airways Corporation (NASDAQ:JBLU), worth close to $58.9 million, comprising 1.6% of its total 13F portfolio. The second largest stake is held by Jim Simons of Renaissance Technologies, with a $34.8 million position; 0.1% of its 13F portfolio is allocated to the company. Other hedgies that are bullish include Cliff Asness’s AQR Capital Management, Claes Fornell’s CSat Investment Advisory and David Keidan’s Buckingham Capital Management.

Now, particular hedge funds have been driving this bullishness. Whitebox Advisors, managed by Andy Redleaf, initiated the largest position in JetBlue Airways Corporation (NASDAQ:JBLU). Whitebox Advisors had 63.6 million invested in the company at the end of the quarter. Matt Sirovich and Jeremy Mindich’s Scopia Capital also made a $58.9 million investment in the stock during the quarter. The following funds were also among the new JBLU investors: Michael Johnston’s Steelhead Partners, Jim Simons’s Renaissance Technologies, and Andy Redleaf’s Whitebox Advisors.

What do corporate executives and insiders think about JetBlue Airways Corporation (NASDAQ:JBLU)?

Bullish insider trading is best served when the company we’re looking at has seen transactions within the past half-year. Over the last 180-day time frame, JetBlue Airways Corporation (NASDAQ:JBLU) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to JetBlue Airways Corporation (NASDAQ:JBLU). These stocks are Copa Holdings, S.A. (NYSE:CPA), Alaska Air Group, Inc. (NYSE:ALK), SkyWest, Inc. (NASDAQ:SKYW), Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL), and Allegiant Travel Company (NASDAQ:ALGT). This group of stocks belong to the regional airlines industry and their market caps are closest to JBLU’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!